Ketamine, Psychotherapy and Depression: What Does the Evidence Currently Tell Us?

Ketamine and Depression: What Does the Evidence Currently Tell Us?

Depression can narrow a person’s world. Things that once felt meaningful may begin to feel distant, relationships can become harder to maintain, and even ordinary tasks may require an exhausting amount of effort. For some people, antidepressant medication, psychotherapy or a combination of the two can bring real and lasting improvement. For others, the path is far less straightforward.

This is one reason ketamine has attracted so much attention. Research has suggested that some people experience a reduction in depressive symptoms within hours or days rather than waiting several weeks for a conventional antidepressant to take effect. For someone who has lived with severe depression for years, that possibility can understandably feel significant.

However, rapid change is not the same as complete or lasting recovery. Not everyone responds to ketamine, improvements may fade, and the treatment carries risks that need to be carefully considered. There are also important differences between receiving ketamine as a medical intervention and taking part in a wider programme that includes psychological preparation, therapeutic support and integration.

This article looks at what the evidence currently suggests, where the uncertainties remain, and how psychotherapy may fit into the wider treatment process.

Why New Approaches to Depression Are Being Explored

Depression is often spoken about as though it were one clearly defined condition with one cause and one treatment. In reality, people arrive at depression through many different routes.

For some, it may follow loss, trauma, chronic stress or the breakdown of an important relationship. For others, it may be connected with longstanding patterns of shame, self-criticism, emotional neglect or a feeling of never being safe enough to fully relax. Physical illness, loneliness, financial pressure, hormonal changes, sleep difficulties and inherited vulnerabilities may also play a part.

This complexity helps explain why no single treatment works for everyone.

Many people benefit from antidepressants, psychotherapy, lifestyle changes or a combination of different approaches. However, some continue to experience significant symptoms despite trying more than one treatment. This is sometimes described as treatment-resistant depression.

The term can sound bleak, as though the person themselves is resistant to getting better. That is not what it means. It simply means that the treatments tried so far have not produced enough improvement.

When someone has spent years moving between medications, therapies and services without finding lasting relief, it is understandable that both clinicians and patients begin looking for different approaches. Ketamine research emerged partly from this need.

What Is Ketamine?

Ketamine is not a new medicine. It has been used in healthcare for decades, primarily as an anaesthetic and pain-relieving medication.

Its effects can vary considerably depending on the dose, the route of administration, the person receiving it and the context in which it is used. A dose used during surgery is not the same as a lower dose used in psychiatric research. Medical treatment in a supervised clinical setting is also very different from uncontrolled recreational use.

More recently, ketamine has been studied for its possible effects on depression, particularly in people who have not responded sufficiently to more conventional treatments.

It is important to distinguish between ketamine itself and the way it is used. The medicine can be administered in several forms, including intravenously, intramuscularly or through a nasal spray. Different services may also use different treatment schedules, levels of psychological support and methods of monitoring.

For this reason, the phrase “ketamine treatment” can refer to several quite different clinical experiences.

What the Research Shows About Depression

The most striking finding in ketamine research has been the speed at which some people report improvement.

Conventional antidepressants may take several weeks to produce a noticeable effect. By contrast, some studies involving ketamine have reported reductions in depressive symptoms within hours or days. This has generated particular interest in its use for severe and treatment-resistant depression.

For someone who has felt emotionally trapped for a long time, even a temporary reduction in symptoms can be meaningful. It may become easier to get out of bed, speak to other people, return to neglected routines or imagine that life could feel different.

However, the findings need to be interpreted carefully.

Research tells us about average changes across groups of participants. It cannot predict with certainty what will happen for one particular person. Some people experience a significant improvement, some notice only a modest change, and others experience little or no benefit.

The size and duration of the response also vary. A person may feel better after one treatment but find that symptoms gradually return. Another may require repeated treatments before noticing a change. Some may respond initially but not maintain that response over time.

The evidence therefore suggests that ketamine can reduce depressive symptoms relatively quickly for some people. It does not mean that it will work rapidly, completely or permanently for everyone.

Rapid Improvement Does Not Always Mean Lasting Recovery

When someone has been severely depressed, an early improvement can feel dramatic. The heaviness may lift, thinking may become clearer, and possibilities that previously seemed unreachable may begin to feel available again.

That change should not be dismissed. It may offer genuine relief and create a period in which the person has more emotional and mental capacity to engage with life.

But there is an important difference between feeling better and understanding what has contributed to the depression.

Depression is rarely experienced only as a collection of symptoms. It often exists within a person’s relationships, beliefs, memories, habits and expectations. Someone may feel temporarily less depressed while continuing to live with the same isolation, unresolved trauma, destructive relationship patterns or deeply embedded sense of worthlessness.

This does not mean the symptom relief is unimportant. It means that relief may represent the beginning of a process rather than the end of one.

A person who has been struggling to stay afloat may first need enough relief to breathe. Once that happens, there may be an opportunity to look at what repeatedly pulls them beneath the surface.

This is where the distinction between rapid response and sustained recovery becomes important. The immediate effect may open a door, but it does not determine what happens after the door has opened.

How Ketamine May Affect the Brain

Ketamine appears to work differently from conventional antidepressants.

Much of the research has focused on glutamate, one of the brain’s major chemical messengers. Ketamine affects a particular type of glutamate receptor known as the NMDA receptor and may influence wider processes involved in communication between brain cells.

Researchers have also studied ketamine’s relationship with neuroplasticity. Neuroplasticity refers to the brain’s ability to adapt, learn and reorganise itself in response to experience.

It is sometimes described in simplified language as “rewiring the brain.” That phrase can be misleading. The brain is not a machine in which a faulty wire is simply removed and replaced. Psychological change involves living systems, repeated experiences, emotional learning and the relationships a person has with themselves and others.

Ketamine may temporarily influence processes connected with learning and synaptic change. This could help explain why some people describe feeling mentally less rigid or more able to view their lives from a different perspective.

However, neuroplasticity is not automatically positive. The brain can strengthen helpful patterns, but it can also reinforce unhelpful ones. What happens during a period of increased flexibility may therefore matter.

If a person returns immediately to the same environment, beliefs and behaviours without support, the opportunity for change may be limited. If the period is accompanied by reflection, emotional processing and practical changes, it may become more meaningful.

The biological effect may create greater possibility. It does not decide what that possibility becomes.

Ketamine Treatment and Ketamine-Assisted Psychotherapy Are Not the Same Thing

Ketamine can be offered as a medical treatment without psychotherapy. In this model, the main aim is usually the reduction of depressive symptoms through the pharmacological effect of the medicine.

Ketamine-assisted psychotherapy is a broader term. It usually describes an approach in which ketamine is used alongside psychological preparation, therapeutic support and some form of integration afterwards.

Even then, there is no single universally agreed model of ketamine-assisted psychotherapy.

Different clinics and research studies may use different doses, routes of administration and treatment schedules. Some sessions may involve active conversation, while others may involve very little talking during the medicine experience. The psychotherapy itself may be based on trauma therapy, psychodynamic work, cognitive approaches, acceptance-based models, somatic therapy or a combination of different traditions.

The role of the therapist may also vary. Some therapists provide quiet support during the experience, while others work more actively. Some programmes include extensive preparation and integration, while others offer only brief check-ins.

For this reason, two people who both say they have received ketamine-assisted psychotherapy may have experienced very different forms of treatment.

It is therefore important not to assume that ketamine-assisted psychotherapy is one standardised intervention with one agreed method and one predictable outcome.

Where Psychotherapy May Fit

Psychotherapy may help a person understand what the change in mood or perspective means within the wider context of their life.

A reduction in depressive symptoms can create psychological space. The person may feel less overwhelmed by their own thoughts, less trapped inside familiar emotional reactions or more able to approach memories that previously felt unbearable.

Some people report experiencing emotions, images or memories during ketamine treatment. Others describe a sense of distance from their ordinary identity, a feeling of connection or an ability to observe their life from a different position. Some experience very little that feels dramatic.

None of these experiences automatically carries a clear meaning.

A powerful image is not necessarily a hidden truth. A difficult memory does not always need to be taken literally. A feeling of insight can be valuable, but it still needs to be considered carefully.

Psychotherapy can provide a place in which the person does not have to rush to explain or act upon everything they experienced. It can help them remain curious.

The therapist and client may explore whether a particular experience connects with earlier relationships, unresolved grief, protective behaviours or beliefs the person has carried for many years. They may also consider what needs to change in the person’s present life rather than focusing only on the past.

The aim is not to impose an interpretation. It is to help the person develop their own understanding and decide what, if anything, should be carried forward.

Preparation, Support and Integration

A psychologically informed approach usually involves more than the medicine session itself.

Preparation, support and integration are often described as separate stages, although in practice they overlap.

Preparation Before Treatment

Preparation involves understanding the person, not simply preparing them for the effects of a drug.

This may include exploring their current symptoms, personal history, relationships, emotional coping strategies and reasons for seeking treatment. It may also involve discussing fears, expectations and previous experiences with altered states of consciousness.

Expectations matter. Someone who believes they must have a dramatic breakthrough may feel disappointed by a quieter experience. Another person may become frightened if unexpected memories or emotions arise.

Preparation can help reduce the pressure to achieve a particular outcome. It allows the person to understand that the experience may be emotional, confusing, peaceful, uncomfortable, insightful or difficult to describe.

It can also establish ways of responding if anxiety develops. The person may be reminded that they do not have to control every moment and that difficult sensations can often be approached gradually rather than fought against.

Good preparation is not about promising that the experience will be positive. It is about helping the person enter it with realistic expectations and a sense of psychological safety.

Psychological Support During Treatment

The environment surrounding ketamine treatment can influence how the experience is felt.

A quiet room, clear boundaries and the presence of trusted clinicians may help the person feel safe enough to allow the experience to unfold. Music, lighting and other aspects of the environment can also affect the emotional tone.

Support should not mean forcing the person towards a predetermined experience. The therapist does not need to search for trauma, demand emotional release or decide what the person is supposed to discover.

Sometimes the most helpful role is simply to remain present.

A person may need reassurance that they are physically safe. They may need help staying connected with their breathing or body. At other times, they may need space without conversation.

The balance between support and interference is important. The experience belongs to the person receiving treatment. The clinician’s role is to help maintain safety without taking control of it.

Integration After Treatment

Integration is the process of considering what happened and how it relates to ordinary life.

This may begin within hours or days of the session, but it is not limited to one conversation. Some experiences make sense quickly. Others continue to unfold over a longer period.

Integration may involve talking through emotions, memories or images that arose. It can also involve noticing changes that were less dramatic, such as feeling more patient, less defended or more willing to contact another person.

The practical side of integration is equally important.

A person may realise that a relationship needs clearer boundaries, but the insight only becomes useful when they begin setting those boundaries. They may recognise how isolated they have become, but recovery requires the difficult step of reconnecting. They may feel compassion towards a younger part of themselves, but that compassion needs to influence the way they respond to themselves when they make mistakes.

Integration turns an experience into a process.

It asks not only, “What did this mean?” but also, “What will I do differently because of it?”

What the Evidence Does Not Yet Establish

Ketamine research has produced important findings, but many questions remain unresolved.

One of the central questions is durability. Researchers continue to examine how long improvements last and what helps people maintain them. A rapid response is clinically valuable, but long-term wellbeing matters more than a brief reduction in a symptom score.

There is also no perfect way of predicting who will respond. A person’s diagnosis, history, medication, biology, expectations and psychological circumstances may all influence the outcome.

Questions also remain about frequency and duration. The ideal number of treatments has not been clearly established for every patient group. More treatment is not automatically better, particularly when repeated exposure may bring additional risks.

The importance of the subjective experience is another area of debate. Some people believe that dissociative or psychedelic-type effects are central to the therapeutic process. Others argue that the antidepressant effect may occur primarily through biological mechanisms.

The role of psychotherapy also requires further study.

It is plausible that preparation and integration may help people make better use of temporary improvements in mood or flexibility. However, ketamine-assisted psychotherapy has not yet been standardised in the same way as many established psychological treatments. Different studies use different approaches, making direct comparison difficult.

The evidence is developing. It contains reasons for serious interest, but it does not answer every clinical question.

Risks, Side Effects and Limitations

Ketamine should not be considered harmless simply because it is being used in a therapeutic context.

During or shortly after treatment, people may experience dissociation, altered perception, dizziness, nausea, anxiety or emotional distress. Coordination and judgement may be affected, which is why people should not drive or undertake safety-sensitive activities until they have been advised that it is safe to do so.

Ketamine can also temporarily increase blood pressure and heart rate. This makes appropriate medical screening and monitoring important, particularly for people with cardiovascular concerns.

Some experiences can be psychologically difficult. A person may feel frightened by a loss of control, become overwhelmed by emotion or encounter memories they were not expecting. A supportive environment may reduce these risks, but it cannot guarantee that every experience will feel calm or meaningful.

There are also concerns associated with repeated or heavy use. Ketamine can be misused, and tolerance or dependence may develop. Frequent exposure, particularly in uncontrolled settings, has been associated with serious urinary and bladder problems. Liver and cognitive concerns have also been investigated.

The level of risk is influenced by dose, frequency, duration, medical history and the way treatment is supervised.

Responsible care requires more than providing ketamine in an attractive room. It involves careful prescribing, appropriate monitoring, honest discussion of uncertainty and a willingness to decide that treatment is not suitable.

Who May Not Be Suitable?

Suitability cannot be determined by reading an article or completing a simple online questionnaire.

Ketamine affects both the body and the mind. A proper assessment should therefore consider physical health, psychiatric history, current medication, substance use, previous treatments and the person’s ability to engage safely with the process.

Additional caution or exclusion may be necessary for people with uncontrolled cardiovascular problems, active psychosis, mania, pregnancy, certain medical conditions or significant difficulties with substance misuse.

Severe depression can also involve suicidal thinking, self-neglect, psychotic symptoms or major disruption to everyday functioning. In these circumstances, the question is not simply whether someone might benefit from ketamine. The wider level of risk, support and clinical responsibility must also be considered.

A person may be very interested in treatment and still not be clinically suitable for it. Equally, someone who appears physically suitable may need additional psychological support before proceeding.

A careful assessment is not an obstacle placed in the way of treatment. It is part of the treatment.

What Can Personal Experiences Tell Us?

Personal accounts of ketamine treatment can be powerful.

Someone may describe feeling relief for the first time in years, reconnecting with emotions they believed had disappeared or seeing their life from a completely different perspective. These stories can provide hope and help others understand what treatment may feel like.

However, an individual account cannot establish whether a treatment is effective in general.

People who have dramatic or positive experiences may be more likely to write about them. Those who experience little benefit, feel disappointed or discontinue treatment may be less visible. This can create a distorted impression of how predictable the outcomes are.

It is also difficult to separate the effect of ketamine from everything happening around it. A person may also be receiving psychotherapy, changing medication, improving sleep, taking time away from work or receiving more support from family.

Expectations can influence how an experience is interpreted. When someone has invested emotionally and financially in a treatment, there may be a natural desire for it to have been worthwhile.

None of this means personal stories are unimportant or untrue. They can reveal aspects of treatment that formal research does not always capture. They should simply be understood as individual experiences rather than promises of what another person will feel.

The Current Place of Ketamine in Depression Care

Ketamine may have an important place within specialist depression care for some people, particularly when established treatments have not produced sufficient improvement.

Its value may lie partly in the possibility of relatively rapid symptom reduction. For a person who has become deeply withdrawn or hopeless, that period of relief may help them re-engage with therapy, relationships and daily life.

However, ketamine should not be presented as replacing every other form of treatment.

Depression may require ongoing psychotherapy, medication management, attention to physical health, practical support and changes in the person’s environment. Some people need help rebuilding relationships or returning to meaningful activity. Others need support processing trauma, grief or longstanding emotional patterns.

The treatment plan should be based on the whole person.

This includes their diagnosis and symptoms, but also their history, relationships, strengths, risks, resources and hopes for the future.

Ketamine may become one part of that plan. It should not be mistaken for the plan itself.

Questions for Future Research

The next stage of ketamine research needs to look beyond whether symptoms can change quickly.

Researchers need to understand which people are most likely to benefit and which factors predict a poor or unsafe response. More information is also needed about how improvements can be maintained without exposing people to unnecessary long-term risk.

The relationship between ketamine and psychotherapy requires further study. We need to know whether particular therapeutic approaches are more helpful, how preparation and integration should be structured, and whether the timing of psychotherapy influences outcomes.

The significance of the subjective experience also remains uncertain. It is not yet clear whether particular altered states contribute directly to improvement or whether they accompany biological processes that would occur regardless.

Long-term outcomes are especially important.

A reduction in a depression score matters, but people also care about whether they can return to work, reconnect with their families, experience pleasure, sleep better and feel more able to cope with ordinary life.

The most useful research will therefore examine not only whether ketamine produces rapid change, but whether that change leads to safer, fuller and more sustainable lives.

A Promising Area of Research, Not a Simple Answer

Ketamine has changed the conversation about depression.

It has challenged the assumption that improvement must always take several weeks to appear and has offered a possible new direction for some people who have not benefited sufficiently from established treatments.

That deserves serious attention.

At the same time, hope should not be allowed to become certainty. Not everyone responds. Improvements may not last. Difficult experiences can occur, and repeated exposure carries risks that should not be minimised.

The evidence for combining ketamine with psychotherapy is developing, but there is still much to learn about which approaches are most effective and who is most likely to benefit.

Perhaps the most balanced way to understand ketamine is not as a cure, but as something that may create an opportunity.

For some people, it may reduce the intensity of depression enough for movement to become possible. It may create distance from familiar thoughts, soften emotional defences or allow a different perspective to emerge.

What happens next remains important.

The medicine cannot repair a relationship, change a person’s circumstances or decide how they will live. It cannot complete the psychological work on their behalf.

Ketamine may help open the door, but lasting change is usually built through what the person is able to understand, practise and carry into the rest of their life.

About This Article

This article provides general educational information about ketamine research, depression and psychotherapy. It does not recommend a particular treatment or determine whether ketamine is suitable for any individual. Decisions involving prescription-only medicines require a full assessment and must be made by an appropriately qualified medical professional.